Dr Caples is Victoria's Lead Scientist, a role that aligns and connects Victoria’s science, technology and innovation capability with business needs and with government’s economic development activities.

Dr Caples is Chair of mRNA Victoria's Scientific Advisory Group; Chair of the Victorian Quantum Technology Network; and a non-executive Director of Agriculture Victoria Services Pty Ltd. 

She has led the development of industry and science and innovation policy in Victoria since joining the Victorian Public Service in 2002 as the inaugural Director of Biotechnology. During this time, she has delivered major policy reforms, a range of programs and global partnerships, and landmark initiatives including the Victorian Comprehensive Cancer Centre.

Dr Caples is experienced in clinical trials, regulatory affairs, business development and licensing through prior roles with international pharmaceutical and biotechnology companies.

An internationally recognised leader in digital health and health informatics, Dr Schaper is on a mission to fix healthcare. A transformational leader, she is driven by driving change and delivering outcomes in the health sector. 

Dr Schaper holds a PhD in technology acceptance among health professionals, is a graduate of Stanford’s Executive Leadership Program, a Certified Health Informatician, a Salzburg Global Seminar Fellow and a Fellow of both the Australasian Institute of Digital Health and the International Academy for Health Sciences Informatics. 

Prof Gibbs is a laboratory head at the Walter and Eliza Hall Institute where he is also joint head of the Personalized Oncology Division. His laboratory is focused leveraging clinical registries and on translational research by combining with tissue-based research, now across many cancer types. 

His personal focus is on colorectal cancer, particularly data and biomarker studies, including co-leading large studies of ctDNA informed therapy for early stage colorectal and pancreas cancer. He has over 400 publications. Prof Gibbs also works as a medical oncologist at the Western Hospital.

Dr Lee is a Medical Oncologist at the Peter MacCallum Cancer Centre & Northern Health hospital, and a Clinical Researcher at WEHI. Dr Lee is the Cancer Services Research Lead and heads the Cancer Clinical Trials unit at Northern Health.

Dr Lee is the Chief Investigator of the PURPLE Pancreatic cancer Translational Registry a collaborative research platform she established in 2016. She co-chairs the DYNAMIC-pancreas trial, DIRECT-InspIRE trial, and the Pancreatic cancer biomarker study. Dr Lee was awarded the Hemstritch Centenary Fellowship (2016), the Kellaway Excellence Award for Translational Research (2020) and selected for the Victorian Premiers Awards for Excellence in Health and Medical Research (2021).

Dr Wong is a Clinical Research Fellow at the Gibbs Lab at the Walter and Eliza Hall Institute.

Dr Gard is a clinical research fellow at the Walter and Eliza Hall Institute (WEHI) and a medical oncologist at Western Health in Melbourne. Her research work focuses on patient education initiatives, repurposing real world registries and meaningfully incorporating consumers into cancer research. Clinically her focus is on lung and genitourinary cancers. 

Dr Dunn is a Clinical Research fellow at the Walter and Eliza Hall Institute (WEHI), where her work is leveraging data collected by clinical cancer registries to examine the quality of cancer care and explore novel avenues for quality improvement. 

Dr Dunn also works as a medical oncologist at Barwon Health and Epworth Geelong.

A/Prof Tran is a medical oncologist at Peter MacCallum Cancer Centre where he leads the genitourinary (GU) medical oncology group and trials program.  He also leads the GU research program at the Walter and Eliza Hall Institute where he focuses on Real World Evidence.

A/Prof Tran leads multi-national registries in Prostate cancer, Urothelial cancer, Testis cancer and Kidney cancer. Data from these registries have been utilized to describe treatment patterns, identify clinical and tissue-based biomarkers and inform future research strategies.  

He is an Associate Professor at the University of Melbourne, chairs the Phase 1 Group within Cancer Trials Australia and the Germ Cell Tumour group within ANZUP.

Dr Anton is a Clinical Research Fellow at the Gibbs Lab at the Walter and Eliza Hall Institute.

Dr Miranda Smith is passionate about community engagement, scientific communication and equity in public health. She co-ordinates the Australian Partnership for Preparedness Research on Infectious diSease Emergencies (APPRISE). In this role, she provides strategic research support and leadership to the executive and research teams, engaging with a diverse network of researchers, policy makers, community representatives and other stakeholders. 

She also contributes to research projects on community engagement, public health and biobanking. Dr Smith has a background in laboratory research, with a PhD and postdoctoral experience in basic and clinical HIV research. She has recently been appointed as the co-chair of the Doherty Institute Community Advisory Board.

A/Prof Phillip Antippa is a specialist cardiothoracic surgeon and the Head of Thoracic Surgical Services at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre, as part of the Victorian Comprehensive Cancer Centre.

His major research interests include lung cancer, pulmonary metastasectomy and traumatic rib osteosynthesis. His special interest in medical informatics has led Phillip to develop systems including electronic patient records and audit and research databases including the construction of Australasia’s Registry for Thoracic Surgery (ANZTHOR) and the international Registry for Rib Fixation (CWIS CIID).

A/Prof Antippa is an Associate Professor in the Department of Surgery at the University of Melbourne. He is also the thoracic surgery representative for the Australasian College of Surgeons Board of Studies for Cardiothoracic Surgery and also sits on the board of the Thoracic Oncology Group of Australasia. He sits on many other national and international committees involved with lung cancer, thoracic surgery and chest wall surgery.

In January 2020, Phillip received the Medal of the Order of Australia for his services to thoracic surgery and to music.

Dr Drosdowsky is a postdoctoral research fellow in the Department of General Practice and Primary Care at the University of Melbourne, where her work focuses on using data to improve cancer care and reduce inequities throughout the entire diagnostic and treatment pathway, and applying novel statistical methodologies to improve the utility of health datasets.

In addition, she is an experienced health services researcher at the Peter MacCallum Cancer Centre, where she has provided biostatistics and quantitative methodology expertise for over a decade, enabling the successful design and analysis of research projects to improve patient outcomes.

Dr Anthony Zimmermann has been working as a senior staff Specialist at the Lyell McEwin Hospital, Elizabeth Vale, Adelaide since 2003. He has been the Head of Diabetes and Endocrine Services, Northern Adelaide Local Health Network (NALHN) since 2013. His unit was awarded a SA Health Award in 2017 for Enhancing Hospital Care for his project titled, "Moving Diabetes Outpatient Care into the 21st Century" and again in 2018 for Excellence and Innovation in Aboriginal Health for a project titled "Integrating Care - Closing the Gap on Diabetes". 

He is a Senior Clinical Lecturer in the Department of Medicine at the University of Adelaide. He is an enthusiastic mentor for undergraduate and postgraduate medical trainees and has earned citations for excellence in clinical teaching, School of Medicine, University of Adelaide. He is a Principal Investigator for the Australasian Diabetes Data Network (ADDN3).

He is an enthusiastic cyclist and Life Member of the Juvenile Diabetes Research Foundation (JDRF) cycling club.

Prof Thursky is an infectious diseases physician and health services researcher who has over 20 years’ experience in the fields of antimicrobial stewardship and infections in the immunocompromised host. She has successfully implemented and scaled programs to improve the quality and safety of healthcare and has a national leadership role in antimicrobial stewardship and sepsis.

Her roles include the Associate Director of Health Services Research and Implementation and the implementation stream for the NHMRC National Centre for Infections in Cancer Sciences at Peter MacCallum Cancer Hospital. In her role at the Doherty Institute, Karin leads the National Centre for Antimicrobial Stewardship which takes a One Health approach to AMS across all human and animal health sectors, and is the Director of the Guidance Group at the Royal Melbourne Hospital which develops, implements and scales information technology to support the judicious use of antimicrobials.

A/Prof Ashley Ng is a clinical haematologist in the Clinical Haematology Department, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Clinical Informatics Lead in the Department of Health Services Research at Peter MacCallum Cancer Centre, and Clinician Researcher at the Walter and Eliza Hall Institute (WEHI). 

In addition, A/Prof Ng co-leads the development of the Clinical and Genomics registries for the Asia Pacific Leukaemia Consortium and is a member of the American Society of Hematology Adolescent and Young Adult Acute Lymphoblastic Leukemia Clinical Guidelines committee. At the Department of Health Services Research, he leads the development of Clinical Informatics for Department of Health Services Research at Peter MacCallum Cancer Centre, with expertise in the EPIC EHR, clinical registry design and development, clinical informatic data linkage, and clinical analytic approaches.

A/Prof Capurro is the Deputy Director of the Centre for Digital Transformation of health where he co-leads the Digital health Validitron (a pipeline to validate digital health innovations in a way similar to what happens with drugs and vaccines) and the Data Science stream.

He was the Chief Medical Information Officer for Chile's Catholic University university healthcare network (2 hospitals, 11 clinics) for 4 years and founded the Chilean National Centre for Health Information Systems, a 
5-university initiative to implement healthcare information interoperability standards and to develop the health informatics workforce in the Chile.

Ms Khanina  is an experienced clinical pharmacist and early career researcher specialising in quality improvement for antimicrobial prescribing and infectious disease management in hospital settings. 

She leads an innovative project aimed at developing an automated surveillance program for infections in cancer patients, emphasising the extraction and transformation of data from electronic medical records to create robust infection detection algorithms. 

Ms Khanina is currently pursuing a PhD focused on developing tools to enhance antifungal stewardship on a national scale.

Prof Chapman is the Associate Dean of Digital Health and Informatics at the University of Melbourne, as well as the Director of the Centre for Digital Transformation of Health. She is an elected fellow of the American College of Medical Informatics and the US National Academy of Medicine and serves as a Board member of the Australasian Institute of Digital Health.

Prof Chapman’s research aims to leverage data and digital technology to transform healthcare delivery. She spent two decades developing and evaluating 
AI / natural language processing algorithms and has led many multidisciplinary programs of work focused on research, education, and application of digital health. Her current passion is how to best design, implement, and validate digital innovations like AI and virtual care in healthcare settings.

Dr Rozova is a data scientist and a machine learning practitioner passionate about developing automated systems to improve patient care. She trained in Applied Mathematics and Computer Science and is currently a Postdoctoral Research Fellow with the Centre for Digital Transformation of Health at the University of Melbourne.

Dr Rozova works with stakeholders of diverse backgrounds to build solutions that address user needs. Her research interests lie at the intersection of artificial intelligence, health informatics, and digital health, and involve the application of machine learning, natural language processing, and image analysis methods to complex biomedical and clinical documentation datasets. 

A/Prof Cooper is an experienced researcher and consultant in digital health, and is the Director of Calliston Consultants Pty Ltd. He is an Affiliate A/Prof. Unit Chair, Faculty of Health and the Deakin University School of Medicine, assisting in syllabus and research in Health Informatics.

A/Prof Cooper is a Fellow of the Australasian Society of Health Informaticians and a Certified Health Informatician (Australia). and is a Member of the Expert Advisory Group on Building Trust and Confidence in Health and Data. A/Prof Cooper is also the Deputy Chair of BioGrid Australia and an Editor for the Pomegranate podcast of the Royal Australasian College of Physicians.

Mark Nevin is CEO of Cancer Council Australia (CCA), which exists to reduce the incidence and impact of all cancers for all Australians. 

Mr Nevin has held executive leadership positions in Australian and international healthcare peak bodies for the past 15 years leading strategy, policy development, regulatory affairs, standards and advocacy. He has wide-ranging experience in governance, health reform, program management, prevention, screening and the adoption of new clinical and digital technologies. He has also worked in consulting, advising governments on strategy development, implementation of new care pathways and the adoption of leading-edge technologies across Australia.

Before joining CCA, Mr Nevin served as CEO of the Royal Australian and New Zealand College of Radiologists (RANZCR) during the pandemic, and more recently as CEO of the Australasian Institute of Digital Health (AIDH). 

He originally practised as a clinician in optometry before retraining in economics, politics and governance.  In 2020, Mr Nevin was awarded a Fellowship of AIDH in recognition of his pioneering work in telehealth and artificial intelligence

Dr Duong is an Emergency Physician with a keen interest in critical care medicine and technology.  As the CMIO for Monash and a practicing physician, he has a keen interest in leveraging technology to improve how we currently care for our patients while addressing the increasing demands being put on our clinicians.  

In particular, Dr Duong has a strong interest in data and analytics, and as chair of the ‘Data Governance and Artificial Intelligence Committee’ at Monash Health, aims to break down the data silos within the health system to better connect clinicians with each other, their patients, and their communities, ensuring people have the information they need when they need it to enable data driven decisions.

A/Prof Tam Nguyen has 25 years of working in clinical trials, health and medical research and research management sector including tertiary teaching hospitals, medical research institutes and universities across Australia.

He is the deputy director of research at St Vincent’s Hospital Melbourne, responsible for research strategy, research development, innovation and partnership. Tam serves as non-executive director & advisor to several medtech and health tech start-ups + scale ups.

He's a co-editor of a recent book: AI in Medicine (Springer)

Dr Dang is a Senior Lecturer at the University of Melbourne and a Visiting Fellow at the University of New South Wales, where she also earned her Ph.D. Previously, she served as a Senior Research Scientist at Nokia Bell Labs in the UK and as a Senior Research Associate at the University of Cambridge. 

Her research focuses on human-centered AI and mobile health sensing, particularly on developing AI models that use speech and audio signals (such as breathing) and physiological signals (like PPG and EEG) through mobile and wearable devices to detect and monitor health conditions. Dr Dang is an Editor for IEEE Pervasive Computing and has served on the Senior Program Committee and as an Area Chair for top conferences such as AAAI and ICASSP. She has received several Best/Top Paper Awards and was recognized as one of the Asian Dean’s Forum Rising Stars - Women in Engineering.

Prof Paterson is Professor of Law (Consumer Protection and Emerging Technology) at the Fairness, Transparency and Coherence (FTC) in Consumer and Credit Protection Project at Melbourne Law School.

She is also the Co-Director at the Centre for AI and Digital Ethics, Digital Access and Equity Research Program, Melbourne Social Equity Institute.

Prof Trubiano is an Infectious Diseases Physician and Director of Infectious Diseases at the Murdoch Children's Research Institute. He is an NHMRC Emerging Leadership Fellow at Department of Infectious Diseases, The University of Melbourne and Cross Cutting Discipline Clinical Research Co-Lead at the Doherty Institute. He is the head for the Centre for Antibiotic Allergy and Research at Austin Health. The Centre hosts the National Antibiotic Allergy Network (NAAN) and Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR). 

Prof Trubiano leads clinical and translational studies at Austin Health and Peter MacCallum Cancer Centre investigating drug allergy and infections in the immunocompromised host. One of his current key projects is implementing point-of-care tools and precision medicine approaches for antibiotic allergy to improve prescribing and medication safety in health services.

Ms Mitri is a Drug Allergy Pharmacist within the Antimicrobial Stewardship Team at the Centre for Antibiotic Allergy and Research and Department of Infectious Diseases and Immunology at Austin Health, Victoria. Elise co-ordinates the Austin Health inpatient antibiotic allergy delabelling service which aims to facilitate antibiotic allergy testing while concurrently optimising antimicrobial prescribing. 

Ms Mitri is the Project Manager for the International Network of Antibiotic Allergy Nations (iNAAN) study and is a PhD candidate at the Peter Doherty Institute for Infection and Immunity, University of Melbourne, examining implementation of multi-disciplinary health service antibiotic allergy programs.

Dr Fletcher is an anaesthetics advanced trainee working in public hospitals throughout north-West Victoria. He is an Honorary Research Fellow and PhD Candidate with the Department of Critical Care at the University of Melbourne. 

Dr Fletcher is also a software developer and his passion is to create digital solutions to health problems. He is the lead developer for the National Antibiotic Allergy Network and works closely with the Centre for Antibiotic Allergy Research at Austin Health and BioGrid Australia to deliver a point-of-care smartphone app for the assessment of patient reported penicillin allergies. 

Prof Jo Douglass is the James Stewart Professor of Medicine and Head of the Department of Medicine in the Melbourne Medical School. She also holds the position of Director of Research at the Royal Melbourne Hospital.

She is a physician who trained in Respiratory Medicine and Allergy and Clinical Immunology and from 2012 to 2020 was head of The Department of Immunology and Allergy at the Royal Melbourne Hospital. Prof Douglass trained in Medicine at Monash University and undertook postgraduate training and education at Southampton and in London.  

Prof Douglass is widely published, with over 100 original publications. She is a past president of the Australasian Society of Clinical Immunology and Allergy and is a Fellow of the Thoracic Society of Australia and New Zealand. She has served on numerous consumer groups including being current medical advisor to AusPIPs.

Prof Ken Smith is WEHI’s seventh director.  He commenced in April 2024 after returning to Australia from the UK, where he had been Head of the Department of Medicine at Cambridge University since 2010. 
Throughout his 30-year career, as both a researcher and clinician, Prof Smith has been renowned for his high-quality, innovative research and its impact on patient outcomes. He has been instrumental in forming alliances between industry and academia and has first-hand experience in founding start-up companies and commercial experience with the pharmaceutical industry in the UK, US and Europe. 

Prof Smith has a Doctor of Science from the University of Cambridge and was elected as a Fellow of the Academy of Medical Sciences in 2006, to the American Association of Physicians in 2020, and was awarded the Lister Institute Research Prize in 2007.